BENITEC BIOPHARMA INC's ticker is BNTC and the CUSIP is 08205P100. A total of 19 filers reported holding BENITEC BIOPHARMA INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $48 | +17.1% | 202 | +4.7% | 0.00% | – |
Q1 2023 | $41 | +28.1% | 193 | +1.0% | 0.00% | – |
Q4 2022 | $32 | – | 191 | +267.3% | 0.00% | – |
Q3 2022 | $0 | – | 52 | +10.6% | 0.00% | – |
Q2 2022 | $0 | – | 47 | +9.3% | 0.00% | – |
Q1 2022 | $0 | – | 43 | 0.0% | 0.00% | – |
Q4 2021 | $0 | – | 43 | +4.9% | 0.00% | – |
Q3 2021 | $0 | – | 41 | -14.6% | 0.00% | – |
Q2 2021 | $0 | – | 48 | +71.4% | 0.00% | – |
Q1 2021 | $0 | – | 28 | +3.7% | 0.00% | – |
Q4 2020 | $0 | – | 27 | +350.0% | 0.00% | – |
Q3 2020 | $0 | – | 6 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SUVRETTA CAPITAL MANAGEMENT, LLC | 769,000 | $1,796,000 | 0.06% |
Atom Investors LP | 37,335 | $87,000 | 0.04% |
SILVERARC CAPITAL MANAGEMENT, LLC | 492,880 | $57,000 | 0.02% |
WealthTrust Axiom LLC | 12,950 | $30,000 | 0.01% |
UBS Group AG | 347 | $1,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 43 | $0 | 0.00% |
NORTHERN TRUST CORP | 11,813 | $28,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GROUP ONE TRADING, L.P. | 2,000 | $5,000 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 59,566 | $139,000 | 0.00% |